Anti-CD63 antibodies, conjugates, and their uses

MA52626AUndetermined Publication Date: 2021-03-24REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA52626
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-12-10
Filing Date
2019-05-17
Publication Date
2021-03-24
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.